
Anti-DR3(NT)Antibody
CatalogNo.:2402
Size:100ugIgGinPBS,pH7.4,purifiedbyimmunoaffinitychromatography.
ApoptosisisinducedbycertaincytokinesincludingTNFandFasligandoftheTNFfamilythroughtheirdeathdomain-containingreceptors,TNFR1andFas.AnothercelldeathreceptorwasrecentlyidentifiedanddesignatedDR3,Wsl-1,Apo-3,TRAMP,andLARD.
DR3iswidelyexpressedintissuesenrichedinlymphocytesincludingperipheralblood,thymus,andspleen.LikeTNFR1,DR3inducesapoptosisandNF-Bactivation.
Antigen:Peptidecorrespondingtoaa25-40attheN-terminusofhumanDR3(accessionno.AAQ88676).
HostSpecies:Rabbit
StABIlizers:None
Preservatives:0.02%sodiumazide.
Thisantibodyrecognizesfull-lengthhumanandmouseDR3(59kDa).
APPLICATIONSImmunoblotting:useat1ug/ml.
WesternblotanalysisofDR3inJurkatcelllysatewithanti-DR3(NT)at1ug/ml.
Positivecontrol:WholecelllysatefromJurkatcells.
Thesearerecommendedconcentrations.Endusershoulddetermineoptimalconcentrationsfortheirapplications.
DiluteinPBSormediumwhichisidenticaltothatusedintheassaysystem.
Thisantibodyisstableforatleastone(1)yearat-20oC.Avoidmultiplefreeze-thawcycles.
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.